6533b836fe1ef96bd12a1191

RESEARCH PRODUCT

Synergistic antiangiogenic activity of bexarotene in combination with rosuvastatin by targeting ang-ii-mediated akt/mtor/p70s6k signaling pathway

María José SanzP. EscuderoC FerrandoE FurioLaura PiquerasA. Navarro

subject

BexaroteneP70S6 kinaseChemistrymedicineCancer researchRosuvastatinSignal transductionCardiology and Cardiovascular MedicineProtein kinase BPI3K/AKT/mTOR pathwaymedicine.drughttps://doi.org/10.1016/j.atherosclerosis.2014.05.255